• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于融合的无定形药物分散体在聚合物/增塑剂共混物中的分子建模与模拟。

Molecular modelling and simulation of fusion-based amorphous drug dispersions in polymer/plasticizer blends.

机构信息

Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

出版信息

Eur J Pharm Sci. 2019 Mar 15;130:260-268. doi: 10.1016/j.ejps.2019.02.004. Epub 2019 Feb 5.

DOI:10.1016/j.ejps.2019.02.004
PMID:30735824
Abstract

A realistic molecular description of amorphous drug-polymer-plasticizer matrices, suitable for the preparation of amorphous solid dispersions (ASDs) with the aid of fusion-based techniques, was evaluated. Specifically, the incorporation of two model drugs (i.e. ibuprofen, IBU, and carbamazepine, CBZ) having substantially different thermal properties and glass forming ability, on the molecular representation of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (SOL)/polyethylene glycol (PEG, working as a plasticizer) molecular and thermal properties were evaluated with the aid of classical molecular dynamics (MD) and docking simulations. Results showed good agreement between molecular modelling estimations and experimentally determined properties. Specifically, the computed T values that resulted from MD simulations for IBU-SOL/PEG and CBZ-SOL/PEG (53.8 and 54.2 °C, respectively) were in reasonable agreement with the corresponding values resulting from differential scanning calorimetry (DSC) measurements (49.8 and 50.1 °C), while both molecular modelling and experimental obtained results suggested miscibility among system components. Additionally, interactions between CBZ and SOL observed during MD simulations were verified by FTIR analysis, while MD simulations of the hydration process suggested strong molecular interactions between IBU-SOL and CBZ-SOL.

摘要

评估了一种适用于采用熔融技术制备无定形固体分散体(ASD)的非晶态药物-聚合物-增塑剂基质的现实分子描述。具体来说,通过经典分子动力学(MD)和对接模拟,评估了两种具有显著不同热性能和成玻璃能力的模型药物(即布洛芬(IBU)和卡马西平(CBZ))在聚己内酯-醋酸乙烯酯-聚乙二醇接枝共聚物(SOL)/聚乙二醇(PEG,用作增塑剂)分子和热性能的分子表示中的掺入。结果表明,分子建模估计与实验确定的性质之间具有良好的一致性。具体而言,MD 模拟为 IBU-SOL/PEG 和 CBZ-SOL/PEG 产生的 T 值(分别为 53.8 和 54.2°C)与差示扫描量热法(DSC)测量的相应值(49.8 和 50.1°C)相当合理,而分子建模和实验获得的结果均表明系统成分之间具有混溶性。此外,MD 模拟中观察到的 CBZ 和 SOL 之间的相互作用通过 FTIR 分析得到了验证,而 IBU-SOL 和 CBZ-SOL 水合过程的 MD 模拟表明它们之间存在强烈的分子相互作用。

相似文献

1
Molecular modelling and simulation of fusion-based amorphous drug dispersions in polymer/plasticizer blends.基于融合的无定形药物分散体在聚合物/增塑剂共混物中的分子建模与模拟。
Eur J Pharm Sci. 2019 Mar 15;130:260-268. doi: 10.1016/j.ejps.2019.02.004. Epub 2019 Feb 5.
2
Molecular simulations for amorphous drug formulation: Polymeric matrix properties relevant to hot-melt extrusion.无定形药物制剂的分子模拟:与热熔挤出相关的聚合物基质性质。
Eur J Pharm Sci. 2018 Jul 1;119:259-267. doi: 10.1016/j.ejps.2018.04.035. Epub 2018 Apr 24.
3
Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.基于 Soluplus®-PEG4000 杂化的格列美脲分子相互作用:特性与抗糖尿病研究。
Int J Pharm. 2015 Dec 30;496(2):741-50. doi: 10.1016/j.ijpharm.2015.11.007. Epub 2015 Nov 12.
4
Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.利伐沙班高分子无定形固体分散体:水分诱导的热力学相行为和分子间相互作用。
Eur J Pharm Biopharm. 2019 Dec;145:98-112. doi: 10.1016/j.ejpb.2019.10.010. Epub 2019 Nov 4.
5
Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.应用混合实验设计研究组成对卡马西平热熔挤出固体分散体形成的影响。
J Pharm Pharmacol. 2014 Feb;66(2):232-43. doi: 10.1111/jphp.12199. Epub 2013 Dec 18.
6
Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.热熔挤出法制备卡马西平-Soluplus 固体分散体及热力学模型拟合预测药物-聚合物混合的相容性。
Eur J Pharm Biopharm. 2013 May;84(1):228-37. doi: 10.1016/j.ejpb.2012.12.018. Epub 2013 Jan 18.
7
Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.通过各种方法制备无定形固体分散体时,研究和关联药物-聚合物的混合和分子相互作用。
Eur J Pharm Sci. 2015 Apr 25;71:12-24. doi: 10.1016/j.ejps.2015.02.003. Epub 2015 Feb 14.
8
Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy.拉曼和衰减全反射傅里叶变换红外光谱法在共晶配方定量分析中人工神经网络(ANNs)和偏最小二乘(PLS)回归的应用。
J Pharm Biomed Anal. 2018 Sep 5;158:214-224. doi: 10.1016/j.jpba.2018.06.004. Epub 2018 Jun 4.
9
On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.关于 Soluplus 固有性质及其在微波淬火冷却技术制备布洛芬固体分散体中的应用。
Pharm Dev Technol. 2018 Jul;23(6):573-586. doi: 10.1080/10837450.2016.1256409. Epub 2016 Nov 16.
10
Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity.基于模型的熔体黏度对无定形固体分散体热熔挤出过程的数值模拟。
Eur J Pharm Biopharm. 2018 Mar;124:34-42. doi: 10.1016/j.ejpb.2017.12.001. Epub 2017 Dec 6.

引用本文的文献

1
Baicalein-Loaded Chitosan Films for Local Treatment of Oral Infections.用于口腔感染局部治疗的载黄芩素壳聚糖膜
Polymers (Basel). 2025 Aug 8;17(16):2167. doi: 10.3390/polym17162167.
2
Monitoring of Isothermal Crystallization and Time-Temperature Transformation of Amorphous Felodipine: The Time-Domain Nuclear Magnetic Resonance Method.无定形非洛地平的等温结晶和时-温转变的监测:时域核磁共振法。
AAPS PharmSciTech. 2024 Sep 19;25(7):219. doi: 10.1208/s12249-024-02919-2.
3
Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity.
染料木黄酮与氨基酸的共无定形体系:关于溶解度增强及生物活性的研究
Pharmaceutics. 2023 Nov 21;15(12):2653. doi: 10.3390/pharmaceutics15122653.
4
Composition Dependency of the Flory-Huggins Interaction Parameter in Drug-Polymer Phase Behavior.药物-聚合物相行为中弗洛里-哈金斯相互作用参数的组成依赖性
Pharmaceutics. 2023 Nov 21;15(12):2650. doi: 10.3390/pharmaceutics15122650.
5
Amorphous Pterostilbene Delivery Systems Preparation-Innovative Approach to Preparation Optimization.无定形紫檀芪递送系统的制备——制备优化的创新方法
Pharmaceutics. 2023 Apr 13;15(4):1231. doi: 10.3390/pharmaceutics15041231.
6
Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.连续制造和药物无定形固体分散体的分子建模。
AAPS PharmSciTech. 2022 Sep 2;23(7):249. doi: 10.1208/s12249-022-02408-4.
7
Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review.用于无定形固体分散体的分子间静电相互作用调控中的聚电解质基质:综述
Pharmaceutics. 2021 Sep 14;13(9):1467. doi: 10.3390/pharmaceutics13091467.
8
Structure and Glass Transition Temperature of Amorphous Dispersions of Model Pharmaceuticals with Nucleobases from Molecular Dynamics.基于分子动力学的含核碱基模型药物非晶态分散体的结构与玻璃化转变温度
Pharmaceutics. 2021 Aug 13;13(8):1253. doi: 10.3390/pharmaceutics13081253.
9
Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.三元无定形固体分散体中的药物晶体生长:表面活性剂和聚合物基质载体的影响。
Int J Pharm X. 2021 Jun 5;3:100086. doi: 10.1016/j.ijpx.2021.100086. eCollection 2021 Dec.
10
Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.朝向预测药物-聚合物无定形固体分散体混溶性、稳定性和制剂设计的分子模拟和统计学习方法。
Molecules. 2021 Jan 1;26(1):182. doi: 10.3390/molecules26010182.